NSE · Basic Materials · Specialty Chemicals
with an average price target of ₹370.00.
| Holder | Stake |
|---|---|
| Orbimed Asia III Mauritius FVCI Limited | 12.15% |
| Nalanda India Equity Fund Limited | 8.38% |
| Polunin Emerging Markets Small Cap Fund, LLC | 2.48% |
| Marval Guru Fund | 1.80% |
| Pradip Bhailal Shah | 1.67% |
| Document | Date |
|---|---|
| Q1 FY27 earnings call ADVANCED ENZYME TECHNOLOGIES LIMITED – Q1 FY27 SUMMARY HEADLINE NUMBERS • Revenue: INR 1,898 million, up 2% YoY (from INR 1,859 million in Q1 FY26); | 2026-08-18 |
| Investor presentation · Q1 FY27 ADVANCED ENZYME TECHNOLOGIES LIMITED – Q1 FY27 SUMMARY HEADLINE NUMBERS • Revenue: ₹1,898 million in Q1 FY27, up 2% year-on-year from ₹1,859 million | 2026-08-08 |
| Quarterly results · Q1 FY27 ADVANCED ENZYME TECHNOLOGIES LTD - DOCUMENT SUMMARY HEADLINE NUMBERS • Q1 FY2026-27 Consolidated Revenue: ₹2,033.67 million (unaudited), down from ₹ | 2026-08-08 |
| Annual report FY2026 ADVANCED ENZYME TECHNOLOGIES LIMITED – INTEGRATED ANNUAL REPORT 2025-26 HEADLINE NUMBERS • Revenue from operations: ₹7,458 million (FY 2024-25: ₹6,3 | 2026-07-08 |
| Q4 FY26 earnings call ADVANCED ENZYME TECHNOLOGIES LIMITED – FY26 FINANCIAL SUMMARY HEADLINE NUMBERS • Q4 FY26 Revenue: INR 2,034 million (22% YoY growth, 18% sequential | 2026-05-15 |
| Investor presentation · Q4 FY26 ADVANCED ENZYME TECHNOLOGIES LIMITED - EARNINGS PRESENTATION SUMMARY May 2026 --- HEADLINE NUMBERS • Q4 FY26 Revenue: ₹2,034 million (Q4 FY25: ₹1,6 | 2026-05-09 |
| Quarterly results · Q4 FY26 ADVANCED ENZYME TECHNOLOGIES LIMITED – BOARD MEETING SUMMARY (MAY 09, 2026) HEADLINE NUMBERS • Final Dividend: ₹1.35 per equity share (67.5% on face | 2026-05-09 |
| Q3 FY26 earnings call ADVANCED ENZYME TECHNOLOGIES LIMITED - Q3 & 9M FY26 SUMMARY HEADLINE NUMBERS • Q3 FY26 Revenue: INR 1,719 million (2% Y-o-Y growth; 7% Q-o-Q decline | 2026-02-07 |
Readable in the app.
| Action | Detail | Date |
|---|---|---|
| Dividend | ₹1.35 / share ex-date Jul 24, 2026 | 2026-07-24 |
| Announcement | Date |
|---|---|
| Closure of buyback effective October 30, 2026 Advanced Enzyme Technologies has completed its share buyback through stock exchanges. Between August 14 and October 30, 2026, it bought back 2,410,906 shares at an average price of ₹289.09 p | 2026-10-30 |
| Board approves share buyback program submission to exchange Advanced Enzyme Technologies Limited announced a share buyback program approved by its Board on August 8, 2026. The company will repurchase its own equity shares from the open market through | 2026-08-11 |
| Public announcement of share buyback program initiated Advanced Enzyme Technologies Limited announced a share buyback program on August 11, 2026. The company's board approved repurchasing its own equity shares from the open market through BSE an | 2026-08-11 |
| Acquisition of another business by Advanced Enzyme Technologies Advanced Enzyme Technologies Ltd announced three key corporate actions in their August 2026 board meeting: (1) Approved Q1 FY2027 unaudited financial results, (2) Authorized a share buyback | 2026-08-08 |
| Acquisition announced by Advanced Enzyme Technologies Limited Advanced Enzyme Technologies Limited has informed the Exchange about Acquisition | 2026-01-31 |
Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Advanced Enzyme Technologies Limited — free to start.
Open in the appGoogle PlayApp StoreData updated 2026-11-07.